- Home
- LFT vs ZTEK Comparison
LFT vs ZTEK Comparison
Compare LFT & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFT | ZTEK |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | Canada |
| Employees | N/A | 18 |
| Industry | Real Estate Investment Trusts | Major Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 68.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | LFT | ZTEK |
|---|---|---|
| Price | $1.42 | $0.63 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 134.0K | ★ 134.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.68% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $124.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.26 | $0.54 |
| 52 Week High | $2.84 | $1.84 |
Technical Indicators
Market Signals| Indicator | LFT | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 59.30 | 42.44 |
| Support Level | $1.41 | $0.55 |
| Resistance Level | $1.65 | $0.75 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 96.00 | 53.92 |
Price Performance
Historical ComparisonAbout LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.